Clinical Trial Update: The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the safety of topical PEP005 for the treatment of common warts has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Verruca Vulgaris

Drugs mentioned

• PEP005 (ingenol mebutate)

Snippet

Sponsor: Peplin | Conditions: Warts | Phase 1 | Status: WITHDRAWN